返回顶部

Sharp通过与柯乾医药的合作将其业务扩大至中国

柯乾2023-03-012477

Sharp通过与柯乾医药的合作将其业务扩大至中国。

Sharp是合同包装和临床供应服务的全球领导者,与总部位于中国的柯乾医药建立了战略合作伙伴关系,以扩大其在中国市场的业务覆盖和运作能力。

Sharp将与专门为本地和全球临床试验提供临床供应服务的柯乾医药合作,为Sharp的医药和生物药客户进入中国市场提供便利,同时也帮助中国创新者实现全球化。

该合作关系将使Sharp能够为医药客户的临床研究提供本地专业知识,同时受益于Sharp和柯乾医药之间建立的互惠服务的效率。

柯乾医药是立足于中国覆盖国际的领先的临床试验供应服务提供者。通过和Sharp的战略合作,柯乾医药将进一步提升其国际运作和项目管理能力。通过Sharp的全球设施网络和柯乾医药对中国市场的深入了解和运作经验,柯乾医药将为中国创新药企业能够提供更多更好的全球解决方案,在确保质量和法规遵从性的前提下,更好地体现效率和服务优势。

Sharp Clinical董事总经理Robert O'Beirn表示:“我们很高兴宣布与柯乾医药的合作伙伴关系,这表明我们致力于在蓬勃发展的中国市场支持我们的客户。这一合作关系代表了两个值得信赖、经验丰富的临床服务提供商的联盟,这将确保我们的客户从其临床试验的最佳本地知识和全球影响力中受益。”

柯乾医药创始人兼总经理曹宇峰补充道:“柯乾医药投入大量时间寻找和优化全球合作伙伴,我们对Sharp在临床试验包装市场的经验和广泛专业知识印象深刻。扩大柯乾医药对新市场的影响力,帮助中国创新者进入新的全球市场,是我们未来增长战略的重要组成部分。与Sharp的合作是对实现该战略的重要贡献。

 

Sharp expands its reach to China through partnership with ClinsChain

Sharp, a global leader in contract packaging and clinical supply services, has formed a strategic partnership with China-based ClinsChain to expand its reach and capabilities into the Chinese market.

Sharp will collaborate with ClinsChain - who specialize in providing clinical supply services for local and global clinical trials - to facilitate access to the Chinese market for Sharp’s pharma and biopharma clients, while also helping Chinese innovators to globalise their reach.

The partnership will enable Sharp to offer pharma clients local expertise for their clinical studies,  while benefiting from the efficiency of an established reciprocal service offering between Sharp and ClinsChain.

ClinsChain is a leading clinical trial supply service provider based in China and covering the world. Through strategic cooperation with Sharp, ClinsChain will further improve its international operation and project management capabilities. Through sharp's global facility network and ClinsChain’s in-depth understanding and operation experience of the Chinese market, ClinsChain will provide more and better global solutions for Chinese new drug innovators and better reflect efficiency and service advantages on the premise of ensuring quality and regulatory compliance.

Robert O’Beirn, Managing Director, Sharp Clinical said: “We are delighted to announce our partnership with ClinsChain, demonstrating our commitment to supporting our clients in the burgeoning Chinese market..

“This partnership represents an alliance of two trusted and experienced clinical service providers which will ensure our clients benefit from the best of local knowledge and global reach for their clinical trials.

Paul Cao, Founder, General Manager at ClinsChain added: “ClinsChain has invested significant time looking for a strong global partner and we were very impressed with Sharp’s experience and broad expertise in the clinical trial packaging market.

“Expanding ClinsChains reach to new markets and helping Chinese innovators reach new global markets is a vital part of our growth strategy for the future. This partnership with Sharp is an important contribution to delivering that strategy.”